Marengo Therapeutics
Latest round
- Series A
Last raised
- Jan 2017
Total raised
- $39M
Investors
- 1
About Marengo Therapeutics
Marengo Therapeutics, Inc.Founded in 2015 and headquartered in Cambridge, US, Marengo Therapeutics, Inc. specializes in creating therapeutic solutions through TCR-targeting antibodies.Marengo Therapeutics focuses on developing first-in-class TCR-targeting antibodies aimed at modulating T cell subsets to activate the human immune system. Their products are designed to enhance the immune response against various cancers, catering to hospitals, oncology clinics, and research institutions across North America and Europe, with a focus on the US and select EU markets.Marengo Therapeutics generates revenue through the direct sale of its TCR-targeting antibodies, often under clinical trial agreements that may lead to commercialization. The company engages in B2B relationships with healthcare providers, who procure these products for patient treatments. The company aims to launch new products as it enhances its offerings and seeks entry into new markets, specifically focusing on expanding its presence in Europe and the US by 2023.
Who invested in Marengo Therapeutics
1 investor across 1 round
See all investors in Marengo Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 3, 2017
Amount
$39M
Investors
Questions about Marengo Therapeutics
Who invested in Marengo Therapeutics?
Marengo Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Marengo Therapeutics raised?
Marengo Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Marengo Therapeutics last raise money?
Marengo Therapeutics's most recent round on record is a Series A, in Jan 2017.
What does Marengo Therapeutics do?
Marengo Therapeutics is a biotechnology company.
Where is Marengo Therapeutics headquartered?
Marengo Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Marengo Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Marengo Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Marengo Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.